亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

浙江臺(tái)州市保隆化工有限公司  

抗腫瘤產(chǎn)品,醋酸格拉替雷

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:董女士
  • 電話:86-0576-88702852
  • 郵件:eric@bolonpharm.com
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 醋酸格拉替雷中間體3415-08-5
醋酸格拉替雷中間體3415-08-5
單價(jià) 面議對比
詢價(jià) 暫無
發(fā)貨 浙江付款后3天內(nèi)
過期 長期有效
更新 2014-03-12 14:28
 
詳細(xì)信息

中文名稱:

(4S)-4-[(4-羥基苯基)甲基]-2,5-惡唑烷二酮

中文同義詞:

(4S)-4-[(4-羥基苯基)甲基]-2,5-惡唑烷二酮

英文名稱:

H-TYR-NCA

英文同義詞:

H-TYR-NCA;Tyrosine, NCA;N-Carboxy-L-tyrosine anhydride;(4S)-4-[(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione;L-Tyrosine N-carboxyanhydride;(2,5-Oxazolidinedione,4-[(4-hydroxyphenyl)Methyl]-, (4S)-

CAS號(hào):

3415-08-5

分子式:

C10H9NO4

分子量:

0

EINECS號(hào):

 

Mol文件:

Mol File

©2025 浙江臺(tái)州市保隆化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:4600  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |